Clinical trials
Completed Non-alcoholic Fatty Liver Disease trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
58 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 3 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 4 |
| 2019 | 5 |
| 2020 | 9 |
| 2021 | 5 |
| 2022 | 5 |
| 2023 | 9 |
| 2024 | 3 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 58 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ningbo No. 1 Hospital | 4 |
| Chinese University of Hong Kong | 3 |
| Nanfang Hospital, Southern Medical University | 3 |
| Sunshine Lake Pharma Co., Ltd. | 3 |
| Gannex Pharma Co., Ltd. | 2 |
| Guangdong Raynovent Biotech Co., Ltd | 2 |
| Haisco Pharmaceutical Group Co., Ltd. | 2 |
| Shanghai Zhongshan Hospital | 2 |
| Shaoguan University | 2 |
| The University of Hong Kong | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Non-alcoholic Fatty Liver Disease | 58 |
| Diabetes Mellitus, Type 2 | 6 |
| Obesity | 4 |
| Inflammation | 3 |
| Diabetes Mellitus | 2 |
| Dyslipidemias | 2 |
| Fatty Liver | 2 |
| Hepatitis B, Chronic | 2 |
| Hyperlipidemias | 2 |
| Pediatric Obesity | 2 |
Trials
Showing 1 to 25 of 58. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.